Notch signaling in neuroblastoma

Seminars in Cancer Biology

Volumn 14, Issue 5, 2004, Pages 365-373

  Påhlman, Sven ^a   Stockhausen, Marie Thérése ^a   Fredlund, Erik ^a   Axelson, Håkan ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Differentiation; Hes; Hypoxia; Neuroblastoma; Normoxia; Notch

Indexed keywords

ANTIINFECTIVE AGENT; COMPLEMENTARY DNA; GAMMA SECRETASE INHIBITOR; L 685 458; NOTCH RECEPTOR; OXYGEN; RETINOID; UNCLASSIFIED DRUG;

ADRENAL MEDULLA; ADRENERGIC SYSTEM; AGE; BRAIN HYPOXIA; CELL DIFFERENTIATION; CHEMOTHERAPY; DEVELOPMENTAL STAGE; DNA MICROARRAY; EMBRYO DEVELOPMENT; GENE AMPLIFICATION; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; GROWTH DISORDER; HUMAN; MARKER GENE; NEURAL CREST; NEUROBIOLOGY; NEUROBLASTOMA; NONHUMAN; ONCOGENE C MYC; PHENOTYPE; PROGNOSIS; PROMYELOCYTIC LEUKEMIA; PROTEIN FUNCTION; RETINOBLASTOMA; REVIEW; STEM CELL; TUMOR CELL;

EID: 3342905290     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2004.04.016     Document Type: Article

References (60)

1. Gestblom C., Grynfeld A., Øra I., Örtoft E., Larsson C., Axelson H., et al. The basic helix-loop-helix transcription factor dHAND, a marker gene for the developing human sympathetic nervous system, is expressed in both high- and low-stage neuroblastomas. Lab Invest. 79:1999;67-79
2. Hoehner J.C., Gestblom C., Hedborg F., Sandstedt B., Olsen L., Påhlman S. A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage. Lab Invest. 75:1996;659-675
3. Ciccarone V., Spengler B.A., Meyers M.B., Biedler J.L., Ross R.A. Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res. 49:1989;219-225
4. Hishiki T., Nimura Y., Isogai E., Kondo K., Ichimiya S., Nakamura Y., et al. Glial cell line-derived neurotrophic factor/neurturin-induced differentiation and its enhancement by retinoic acid in primary human neuroblastomas expressing c-Ret. Cancer Res. 58:1998;2158-2165
5. Ross R.A., Spengler B.A., Domenech C., Porubcin M., Rettig W.J., Biedler J.L. Human neuroblastoma I-type cells are malignant neural crest stem cells. Cell Growth Differ. 6:1995;449-456
6. Rostomily R.C., Bermingham-McDonogh O., Berger M.S., Tapscott S.J., Reh T.A., Olson J.M. Expression of neurogenic basic helix-loop-helix genes in primitive neuroectodermal tumors. Cancer Res. 57:1997;3526-3531
7. Shimada H., Chatten J., Newton W.A. Jr., Sachs N., Hamoudi A.B., Chiba T., et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J. Natl. Cancer Inst. 73:1984;405-416
8. Cushing H., Wohlbach B.B. The transformation of a malignant paravertabral sympathicoblastoma into benign ganglioneuroma. Am. J. Pathol. 3:1927;203-215
9. Soignet S.L., Benedetti F., Fleischauer A., Parker B.A., Truglia J.A., Ra Crisp M., et al. Clinical study of 9-cis retinoic acid (LGD1057) in acute promyelocytic leukemia. Leukemia. 12:1998;1518-1521
10. Matthay K.K., Villablanca J.G., Seeger R.C., Stram D.O., Harris R.E., Ramsay N.K., et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy. N. Engl. J. Med. 341:1999;1165-1173
11. Maris J.M., Denny C.T. Focus on embryonal malignancies. Cancer Cell. 2:2002;447-450
12. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70
13. Gammill L.S., Bronner-Fraser M. Neural crest specification: migrating into genomics. Nat. Rev. Neurosci. 4:2003;795-805
14. LeDouarin N. The neural crest. Cambridge: Cambridge University Press; 1982.
15. Wu J., Saint-Jeannet J.P., Klein P.S. Wnt-frizzled signaling in neural crest formation. Trends Neurosci. 26:2003;40-45
16. Liem K.F. Jr., Tremml G., Roelink H., Jessell T.M. Dorsal differentiation of neural plate cells induced by BMP-mediated signals from epidermal ectoderm. Cell. 82:1995;969-979
17. Lo L., Morin X., Brunet J.F., Anderson D.J. Specification of neurotransmitter identity by Phox2 proteins in neural crest stem cells. Neuron. 22:1999;693-705
18. Guillemot F., Lo L.C., Johnson J.E., Auerbach A., Anderson D.J., Joyner A.L. Mammalian achaete-scute homolog 1 is required for the early development of olfactory and autonomic neurons. Cell. 75:1993;463-476
19. Williams R., Lendahl U., Lardelli M. Complementary and combinatorial patterns of Notch gene family expression during early mouse development. Mech. Dev. 53:1995;357-368
20. Endo Y., Osumi N., Wakamatsu Y. Bimodal functions of Notch-mediated signaling are involved in neural crest formation during avian ectoderm development. Development. 129:2002;863-873
21. Coffman C.R., Skoglund P., Harris W.A., Kintner C.R. Expression of an extracellular deletion of Xotch diverts cell fate in Xenopus embryos. Cell. 73:1993;659-671
22. Doupe A.J., Landis S.C., Patterson P.H. Environmental influences in the development of neural crest derivatives: glucocorticoids, growth factors, and chromaffin cell plasticity. J. Neurosci. 5:1985;2119-2142
23. Taxi J. The chromaffin and chromaffin-like cells in the autonomic nervous system. Int. Rev. Cytol. 57:1979;283-343
24. Cuoupland RE. The development and fate of catecholamine secreting endocrine cells. Amsterdam: Elsevier; 1980.
25. West G.B., Shepherd D.M., Hunter R.B., Macgregor A.R. The function of the organs of Zuckerkandl. Clin. Sci. 12:1953;317-325
26. Jaffe N. Neuroblastoma: review of the literature and an examination of factors contributing to its enigmatic charcter. Cancer Treat. Rev. 3:1976;61-82
27. Brodeur G.M. Neuroblastoma: biological insights into a clinical enigma. Nat. Rev. Cancer. 3:2003;203-216
28. Brodeur G.M., Pritchard J., Berthold F., Carlsen N.L., Castel V., Castelberry R.P., et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J. Clin. Oncol. 11:1993;1466-1477
29. Hedborg F., Ohlsson R., Sandstedt B., Grimelius L., Hoehner J.C., Påhlman S. IGF2 expression is a marker for paraganglionic/SIF cell differentiation in neuroblastoma. Am. J. Pathol. 146:1995;833-847
30. Hoehner J.C., Hedborg F., Eriksson L., Sandstedt B., Grimelius L., Olsen L., et al. Developmental gene expression of sympathetic nervous system tumors reflects their histogenesis. Lab. Invest. 78:1998;29-45
31. Gestblom C., Hoehner J.C., Hedborg F., Sandstedt B., Påhlman S. In vivo spontaneous neuronal to neuroendocrine lineage conversion in a subset of neuroblastomas. Am. J. Pathol. 150:1997;107-117
32. Hoehner J.C., Hedborg F., Wiklund H.J., Olsen L., Påhlman S. Cellular death in neuroblastoma: in situ correlation of apoptosis and bcl-2 expression. Int. J. Cancer. 62:1995;19-24
33. Grynfeld A., Påhlman S., Axelson H. Induced neuroblastoma cell differentiation, associated with transient HES-1 activity and reduced HASH-1 expression, is inhibited by Notch1. Int. J. Cancer. 88:2000;401-410
34. Cohen P.S., Chan J.P., Lipkunskaya M., Biedler J.L., Seeger R.C. Expression of stem cell factor and c-kit in human neuroblastoma. The children's cancer group. Blood. 84:1994;3465-3472
35. Edsjö A, Nilsson H, Vandesompele J, Karlsson J, Pattyn F, Culp LA, Speleman F, Påhlman S. Neuroblastoma cells with overexpressed MYCN retain their capacity to undergo neuronal differentiation. Lab Invest 2004;84:406-17.
36. Bown N., Cotterill S., Lastowska M., O'Neill S., Pearson A.D., Plantaz D., et al. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl. J. Med. 340:1999;1954-1961
37. Brodeur G.M., Green A.A., Hayes F.A., Williams K.J., Williams D.L., Tsiatis A.A. Cytogenetic features of human neuroblastomas and cell lines. Cancer Res. 41:1981;4678-4686
38. Artavanis-Tsakonas S., Rand M.D., Lake R.J. Notch signaling: cell fate control and signal integration in development. Science. 284:1999;770-776
39. Morrison S.J., Perez S.E., Qiao Z., Verdi J.M., Hicks C., Weinmaster G., et al. Transient Notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells. Cell. 101:2000;499-510
40. Lo L.C., Johnson J.E., Wuenschell C.W., Saito T., Anderson D.J. Mammalian achaete-scute homolog 1 is transiently expressed by spatially restricted subsets of early neuroepithelial and neural crest cells. Genes. Dev. 5:1991;1524-1537
41. Franklin J.L., Berechid B.E., Cutting F.B., Presente A., Chambers C.B., Foltz D.R., et al. Autonomous and non-autonomous regulation of mammalian neurite development by Notch1 and Delta1. Curr. Biol. 9:1999;1448-1457
42. Levy O.A., Lah J.J., Levey A.I. Notch signaling inhibits PC12 cell neurite outgrowth via RBP-J-dependent and -independent mechanisms. Dev. Neurosci. 24:2002;79-88
43. Van Limpt V.A., Chan A.J., Van Sluis P.G., Caron H.N., Van Noesel C.J., Versteeg R. High delta-like 1 expression in a subset of neuroblastoma cell lines corresponds to a differentiated chromaffin cell type. Int. J. Cancer. 105:2003;61-69
44. Cooper M.J., Hutchins G.M., Cohen P.S., Helman L.J., Mennie R.J., Israel M.A. Human neuroblastoma tumor cell lines correspond to the arrested differentiation of chromaffin adrenal medullary neuroblasts. Cell Growth Differ. 1:1990;149-159
45. Harris A.L. Hypoxia - a key regulatory factor in tumour growth. Nat. Rev. Cancer. 2:2002;38-47
46. Semenza G.L. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol. Med. 8:2002;S62-S67
47. Jögi A., Øra I., Nilsson H., Lindeheim Å., Makino Y., Poellinger L., et al. Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc. Natl. Acad. Sci. USA. 99:2002;76
48. Jögi A, Vallon-Christersson J, Holmqvist L, Axelson H, Borg Å, Påhlman S. Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival and aggressive tumor behavior. Exp Cell Res 2004;295:469-87.
49. Bos R., Zhong H., Hanrahan C.F., Mommers E.C., Semenza G.L., Pinedo H.M., et al. Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J. Natl. Cancer Inst. 93:2001;309-314
50. Seimiya H., Tanji M., Oh-hara T., Tomida A., Naasani I., Tsuruo T. Hypoxia up-regulates telomerase activity via mitogen-activated protein kinase signaling in human solid tumor cells. Biochem. Biophys. Res. Commun. 260:1999;365-370
51. Helczynska K., Kronblad A., Jögi A., Nilsson E., Beckman S., Landberg G., et al. Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ. Cancer Res. 63:2003;1441-1444
52. Meierhan D., el-Ariss C., Neuenschwander M., Sieber M., Stackhouse J.F., Allemann R.K. DNA binding specificity of the basic-helix-loop-helix protein MASH-1. Biochemistry. 34:1995;11026-11036
53. Firulli B.A., Hadzic D.B., McDaid J.R., Firulli A.B. The basic helix-loop-helix transcription factors dHAND and eHAND exhibit dimerization characteristics that suggest complex regulation of function. J. Biol. Chem. 275:2000;33567-33573
54. Persson P., Jögi A., Grynfeld A., Påhlman S., Axelson H. HASH-1 and E2-2 are expressed in human neuroblastoma cells and form a functional complex. Biochem. Biophys. Res. Commun. 274:2000;22-31
55. Bazan N.G., Lukiw W.J. Cyclooxygenase-2 and presenilin-1 gene expression induced by interleukin-1beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells. J. Biol. Chem. 277:2002;30359-30367
56. Liauw J., Nguyen V., Huang J., St George-Hyslop P., Rozmahel R. Differential display analysis of presenilin 1-deficient mouse brains. Brain Res. Mol. Brain Res. 109:2002;56-62
57. Miyamoto Y., Maitra A., Ghosh B., Zechner U., Argani P., Iacobuzio-Donahue C.A., et al. Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell. 3:2003;565-576
58. Maillard I., Pear W.S. Notch and cancer: best to avoid the ups and downs. Cancer Cell. 3:2003;203-205
59. Jögi A., Persson P., Grynfeld A., Påhlman S., Axelson H. Modulation of basic helix-loop-helix transcription complex formation by Id proteins during neuronal differentiation. J. Biol. Chem. 277:2002;9118-9126
60. Ishibashi M., Ang S.L., Shiota K., Nakanishi S., Kageyama R., Guillemot F. Targeted disruption of mammalian hairy and enhancer of split homolog-1 (HES-1) leads to up-regulation of neural helix-loop-helix factors, premature neurogenesis, and severe neural tube defects. Genes. Dev. 9:1995;3136-3148